Pharmaceutical manufacturers have voluntarily withdrawn thousands of applications to register new products with SA’s medicines regulator, as the SA Health Products Regulatory Authority (Sahpra) seeks to clear the huge backlog it inherited when it replaced the Medicines Control Council last February. At the end of 2018 Sahpra estimated that it faced a backlog of 16,000 medicinal product applications, some of which dated back to the early 1990s. The backlog includes applications for new chemical entities, generic copies of older drugs no longer protected by patents and requests to make changes to formulations or suppliers of active pharmaceutical ingredients. Sahpra has worked with the pharmaceutical industry and external consultants to tackle the backlog while redesigning its systems to make sure it never happens again, said board chair Helen Rees. “We have to clear out the past and get it [Sahpra] fit for purpose. You can’t have a functioning regulator with a backlog of that s...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now